Physician profile
Haley C Maxwell
NPI 1639769847
$9,329.06
in general payments reported to CMS, 2019-2025
43 companies · $2,253 in 2025
The $2,253 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,096 · 2022: $1,620 · 2023: $2,274 · 2024: $2,086 · 2025: $2,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,613.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,785.61 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,597.83 | 2021-2025 | |
| Lilly USA, LLC | $879.00 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $781.55 | 2021-2025 | |
| Amgen INC. | $502.91 | 2021-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $471.68 | 2021-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $459.70 | 2021-2025 | |
| Glaxosmithkline, LLC. | $414.37 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $376.66 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $315.02 | 2021-2023 | Rexulti |
| Exact Sciences Corporation | $171.80 | 2023-2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $166.68 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $150.79 | 2021-2025 | Gardasil 9, Capvaxive |
| Harmony Biosciences LLC | $124.46 | 2023 | Wakix |
| Abbott Laboratories | $101.09 | 2022-2023 | Freestyle Libre 2, Proclaim |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.